203 related articles for article (PubMed ID: 22094968)
1. [Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?].
Scharf RE
Dtsch Med Wochenschr; 2011 Nov; 136(47):2403. PubMed ID: 22094968
[No Abstract] [Full Text] [Related]
2. Guideline update. VTE disease: which agents, and when.
Holten KB; Merok J
J Fam Pract; 2009 Mar; 58(3):E1. PubMed ID: 19284934
[No Abstract] [Full Text] [Related]
3. [Prevention and treatment of venous thromboembolism in patients with cancer].
Struve S; Wendtner CM
Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
[No Abstract] [Full Text] [Related]
4. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
5. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices.
Lee AY
Dis Mon; 2005; 51(2-3):150-7. PubMed ID: 15900267
[No Abstract] [Full Text] [Related]
6. Treatment of venous thrombosis.
Lee AY
Cancer Treat Res; 2009; 148():243-57. PubMed ID: 19377928
[No Abstract] [Full Text] [Related]
7. [Possible effect low molecular weight heparin on survival time. New chances for cancer patients?].
MMW Fortschr Med; 2003 May; 145(19):suppl 3-4. PubMed ID: 12813994
[No Abstract] [Full Text] [Related]
8. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
9. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
Hull RD; Pineo GF; Stein P
Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
[No Abstract] [Full Text] [Related]
11. Established venous thromboembolism therapies: heparin, low molecular weight heparins, and vitamin K antagonists, with a discussion of heparin-induced thrombocytopenia.
Pendleton RC; Rodgers GM; Hull RD
Clin Chest Med; 2010 Dec; 31(4):691-706. PubMed ID: 21047576
[TBL] [Abstract][Full Text] [Related]
12. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
13. New antithrombotic drugs: potential for use in oncology.
Levine MN
J Clin Oncol; 2009 Oct; 27(29):4912-8. PubMed ID: 19738103
[TBL] [Abstract][Full Text] [Related]
14. Managing cancer-related venous thromboembolic disease: low-molecular-weight heparins and beyond.
O'Connell CL; Liebman HA
Expert Rev Hematol; 2008 Dec; 1(2):175-82. PubMed ID: 21082922
[TBL] [Abstract][Full Text] [Related]
15. Does antithrombotic therapy improve survival in cancer patients?
Cunningham MS; Preston RJ; O'Donnell JS
Blood Rev; 2009 May; 23(3):129-35. PubMed ID: 19046797
[TBL] [Abstract][Full Text] [Related]
16. The treatment of venous thromboembolism in patients with cancer.
Prandoni P
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.
Pangilinan JM
J Pharm Pract; 2010 Aug; 23(4):294-302. PubMed ID: 21507829
[TBL] [Abstract][Full Text] [Related]
18. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
Tran QN
Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation in the treatment of established venous thromboembolism in patients with cancer.
Lee AY
J Clin Oncol; 2009 Oct; 27(29):4895-901. PubMed ID: 19738121
[TBL] [Abstract][Full Text] [Related]
20. Clinical studies with anticoagulants to improve survival in cancer patients.
Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]